Navina is an innovative healthcare technology company that specializes in artificial intelligence (AI)-powered clinical intelligence platforms. Founded in 2018, Navina is headquartered in New York City. The company was co-founded by Ronen Lavi, who brought extensive experience from his time in Israel’s military intelligence corps and Shay Perera, who previously worked on AI applications within defense. Navina has raised significant funding, with a recent series C round raising $55 million, bringing the total funding to nearly $100 million. This funding enables the company to expand its AI technologies to streamline healthcare management through more integrated data solutions, enhancing diagnostic accuracy and patient care quality.
| Attribute | Information |
|---|---|
| Founding Date | 2018 |
| Headquarters | New York City, USA |
| Founders | Ronen Lavi, Shay Perera |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | Goldman Sachs Alternatives, Vertex Ventures Israel, Grove Ventures |
| Industry | Healthcare Technology |
| Number of Employees | Approximately 173 (April 2025) |
| Major Products/Services | AI Copilot and Clinical Intelligence |
Navina was created to tackle the inefficiencies in healthcare data management and patient care delivery. The company was conceptualized by Ronen Lavi and Shay Perera, who utilized their backgrounds in AI and military intelligence to address the complex data challenges in healthcare. Recognizing the fragmented nature of medical data, Navina sought to unify disparate health records into coherent, actionable insights for clinicians. Since its inception, Navina has focused on developing a platform that integrates machine learning to surface insights from complex data sets, aiding clinicians in diagnosis and patient management. Their early traction was marked by successful partnerships with various healthcare providers keen on adopting AI solutions.
Navina operates by leveraging AI to convert patient data into succinct, actionable formats for healthcare providers. Its flagship product is the AI Copilot, which assists physicians by identifying care gaps and providing comprehensive patient profiles. This innovative platform has positioned Navina as a leader in clinical intelligence, leading to several prestigious industry recognitions.
In 2025, Navina continues to strengthen its position in the healthcare technology market by expanding its AI capabilities to streamline and enhance patient care delivery. The company serves over 1,300 clinics, supporting over 3 million patients and partnering with 10,000 healthcare professionals. Navina's strategic focus on AI-driven insights for healthcare emphasizes reducing administrative burden while improving care quality. Navina’s competitive edge lies in its ability to automate complex workflows, thereby optimizing clinical operations across various healthcare settings. With solid partnerships, including collaborations with major healthcare organizations, the company maintains a robust market position in the AI healthcare landscape.
Navina's emergence as a prominent player in the healthcare technology sector underscores the transformative potential of AI in clinical settings. With significant investments and expanding partnerships, the company is poised to redefine patient data management through its AI-powered solutions. As it continues to innovate and integrate deeper into health ecosystems, Navina is well-positioned to lead the future of value-based care and elevate the standards of patient diagnoses and management. The company's trajectory suggests a sustained impact on industry practices, focusing on holistic healthcare improvements through advanced technology solutions.